Literature DB >> 22482092

Ochronotic arthropathy: diagnosis and management: a critical review.

Emmanouil Drakoulakis1, Dimitrios Varvitsiotis, Georgioss Psarea, John Feroussis.   

Abstract

Alkaptonuria, a rare hereditary metabolic disorder, is characterized by accumulation of homogentisic acid in the connective tissues resulting from lack of the enzyme homogentisic acid oxidase. Ochronosis, dark pigmentation of connective tissues, is the musculoskeletal manifestation of alkaptonuria. In this article, we report the case of a 53-year-old man who had ochronotic arthropathy and advanced degenerative changes in the shoulders managed with bilateral total shoulder arthroplasty. Three-year follow-up results were satisfactory: good range of motion, no pain, and no signs of prosthesis loosening. Shoulder function was significantly improved after surgery, as documented by Constant scores. This case suggests that shoulder prosthesis results are not affected by alkaptonuria.

Entities:  

Mesh:

Year:  2012        PMID: 22482092

Source DB:  PubMed          Journal:  Am J Orthop (Belle Mead NJ)        ISSN: 1078-4519


  4 in total

1.  Ochronotic arthritis of bilateral knees: a case report.

Authors:  Hang Xu; Jianzhao Wang; Fuying Chen; Zengchao Hong; Xiaoyang Zhang; Xiaohui Ji; Decheng Shao
Journal:  Int J Clin Exp Med       Date:  2015-05-15

2.  Ochronosis of the knee with secondary osteoarthritis requiring total knee replacement in a patient with cryptogenic organising pneumonia.

Authors:  Jorrit Jasper; Wieneke Metsaars; Joris Jansen
Journal:  BMJ Case Rep       Date:  2016-05-20

3.  Long-term follow-up of bilateral hip and knee arthroplasty secondary to ochronotic arthropathy.

Authors:  Imran Ilyas; Syed Kashif; Majed F Algashiri; Samar A Rabbani; Sahar S Aldakhil; Omar A Al-Mohrej
Journal:  Arthroplast Today       Date:  2020-02-26

4.  Ochronotic arthropathy-a rare clinical case.

Authors:  André Couto; André Sá Rodrigues; Paulo Oliveira; Manuel Seara
Journal:  Oxf Med Case Reports       Date:  2018-08-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.